RxDoctor Payments Data

Anthony Lim

Hematology & Oncology · Hilo, HINPI 1093804932

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.4% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations.

$1,732in general payments, 2019–2025

Across 116 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$223
  • AstraZeneca$218
  • Astellas Pharma US Inc$194
  • Merck$172
  • Amgen$151
  • Pfizer$140
  • plus $634 from 13 others

What the payments were for

  • Food & beverage$1,58391%
  • Education$1499%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,732 in reported general payments places this provider in the 55th percentile of 42 hematology & oncology providers in Hawaii.

See all hematology & oncology providers in Hawaii

Other hematology & oncology in Hilo

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →